2 unknown, 1 completed, 1 withdrawn. 2 Not applicable, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Chemoprevention: new trials by email Literature Review of Chemoprevention trials Research Report on Chemoprevention
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Seasonal Malaria Chemoprevention Rapid Assessment Study Mozambique Sulfadoxine/pyrimethamine plus amodiaquine - Malaria,Falciparum, Chemoprevention | Phase 4 | Unknown | Malaria Consortium | 1000 | 2024-03-26 | 2024-03-29 |
| Metformin for the Prevention of CRA Recurrence low-dose metformin, high-dose metformin, Placebo - Colorectal Adenoma, Metformin | Not applicable | Unknown | Jing-yuan Fang, MD, Ph. D | 414 | 2020-08-01 | 2021-05-13 |
| Effect of Resveratrol on Serum IGF2 Among African American Women Resveratrol (RSV) - Chemoprevention | Not applicable | Withdrawn | Loma Linda University | 2019-04-24 | 2023-05-09 | |
| Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) Erlotinib (Tarceva) - Primary Sclerosing Cholangitis, Trisomy 7 | Phase 1 | Completed | Mayo Clinic | 6 | 2009-08-01 | 2014-01-10 |
Cholangiocarcinoma (1) · Cholangitis, Sclerosing (1) · Malaria, Falciparum (1)
Adenocarcinoma (1) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Carcinoma (1) · Cholangitis (1) · Digestive System Diseases (1) · Infections (1) · Malaria (1) · Mosquito-Borne Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Parasitic Diseases (1) · Protozoan Infections (1) · Vector Borne Diseases (1)
Amodiaquine (1) · Erlotinib Hydrochloride (1) · Metformin (1) · Pyrimethamine (1) · Resveratrol (1) · Sulfadoxine (1)
Jing-yuan Fang, MD, Ph. D (1) · Loma Linda University (1) · Malaria Consortium (1) · Mayo Clinic (1)
United States (2) · China (1)
Gayathri Nagaraj, MD (1) · Jing-Yuan Fang, Professor (1) · Sam Gudoi (1)